Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
A prevalent issue in cough, cold and allergy (hay fever) remedies is the misuse of cough syrups, often through self-medication with OTC products. To address this concern, a regulatory framework has been implemented restricting the distribution of…
In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…
On a landscape featuring local and international brands, consumers can access a wide array of choices. Brands like Emzolyn and Exiplon are popular among individuals with lower disposable incomes, while international counterparts, including Benylin,…
Locally preferred alternatives, like consuming honey, ginger, and lemon infusions, enjoy widespread popularity among the locals. In households with lower incomes, natural remedies often take precedence as the initial choice before resorting to…
Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…
The removal of mask-wearing and social distancing measures in March 2023 led to rising demand for cough, cold and allergy remedies as respiratory infections increased. Since February 2020, local seasonal influenza in Hong Kong has remained at a low…
As people become more aware of the importance of self-care, there is a growing demand for OTC medications to treat cough and cold. Access to healthcare is limited and as such it is easier to buy OTC medications. Therefore, despite the increase in…
Within OTC consumer health in France, value sales of cough, cold and allergy (hay fever) remedies are continuing to record the fastest growth in 2023, following a dynamic performance the previous year. Within the category, demand for various formats…
In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…
Cough, cold and allergy (hay fever) remedies received a strong sales boost in 2022 due to consumers returning to working in the office more frequently again and kids returning to in-school classes. This led to consumers spending more time among other…
Although the threat from COVID-19 is largely perceived to have past, many consumers continue to worry about how people will react if they sneeze or cough in public. Volume growth of cough, cold and allergy (hay fever) remedies is helping to drive the…
Following the return to normality in the wake of the COVID-19 crisis, with no more lockdowns or movement restrictions, there has been an increase in the spread of cold and flu viruses, as well as a widespread rise in issues caused by hay fever and…
Cough, cold, and allergy (hay fever) remedies is projected to continue to post retail current value growth in 2023, following a severe decline in 2020 due to the Coronavirus (COVID-19) pandemic. Having passed the 2019 pre-pandemic level in 2022, the…
Cough, cold and allergy (hay fever) remedies are enjoying strong growth in 2023 as the category continues to recover from the sharp declines seen during the COVID-19 pandemic. Flu, common coughs and colds and seasonal allergies in the Irish…
Cough, cold and allergy (hay fever) remedies are expected to perform better in 2023 than in the previous year, with positive value and volume growth. As life in Algeria returns to normal, and social contact increases, there is increased coughs, colds…
In 2023, cough, cold, and allergy (hay fever) remedies in India is set to experience moderate single-digit current value growth, driven predominantly by the demand for decongestants. Decongestants is expected to demonstrate above-average growth due…
The pandemic brought about a huge increase in sales of cough, cold and allergy (hay fever) remedies, especially from the end of 2021, with later COVID-19 variants being revealed to have unique symptoms resembling those of the common cold. In February…
During the review period, the flu and allergy season in South Africa was rife specifically during the winter periods. Given the presence of several flu strains and allergies, consumers reached out to cough, cold and allergy (hay fever) products to…
In early 2023, a sixth wave of COVID-19 coincided with an upsurge in cases of the common cold and influenza, creating a "tripledemic" felt across Mexico, the US, and Central American countries, with Mexico experiencing a milder impact. This scenario…
With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…